Iranian Journal of Nuclear Medicine

Iranian Journal of Nuclear Medicine

The Iranian Journal of Nuclear Medicine (Iran J Nucl Med) is an open-access, peer-reviewed journal dedicated to the advancement of nuclear medicine and its related disciplines. In alignment with its mission to support the global scientific community, the journal does not charge any fees for manuscript submission, processing, or publication, thereby providing a cost-free platform for researchers worldwide.

Established in 1993 by the Research Center for Nuclear Medicine at Tehran University of Medical Sciences, the journal is published in collaboration with the Iranian Society of Nuclear Medicine. Since its inception, Iran J Nucl Med has served as a reputable forum for the dissemination of high-quality research in both basic and clinical nuclear medicine sciences.

The journal covers a broad spectrum of topics, including but not limited to molecular imaging, functional and metabolic assessment of diseases, radionuclide therapy, radiopharmacy, radiochemistry, radiobiology, dosimetry, nuclear medicine instrumentation, and computational applications in nuclear medicine. It welcomes original research articles, systematic reviews, meta-analyses, narrative reviews, mini-reviews, short communications, editorials, case reports, and letters to the editor—particularly those addressing emerging global trends, regional advancements, and critical issues in the field.

Initially published in Persian (1993–1994), the journal adopted a bilingual format (Persian and English) from 1994 to 2007, and has been published exclusively in English since early 2008. Iran J Nucl Med maintains an international editorial board and accepts submissions from researchers around the world, aiming to foster scientific exchange and professional education among physicians, technologists, and specialists involved in nuclear medicine.

 

 Iran J Nucl Med is a member of the Committee on Publication Ethics (COPE).

   ********************************************************************

 SCImago Journal & Country Rank
Impact Factor (2024): 0.3
 
 
 
Current Issue: Volume 34, Supplement 1, September 2026, Pages 1-67 

Publication Information

Publisher

Founding Editor
Editor-in-Chief
Language Editor
Executive Assistant

Frequency
Semiannual
Print ISSN
Online ISSN

Keywords Cloud

  • SPECT
  • Nuclear medicine
  • SPECT/CT
  • Myocardial perfusion imaging
  • PET/CT
  • Biodistribution
  • prostate cancer
  • Lymphoscintigraphy
  • PET
  • Breast cancer
  • Scintigraphy
  • Bone scintigraphy
  • Bone scan
  • Gated SPECT
  • Thyroid cancer
  • Monte Carlo
  • quality control
  • [18F]FDG
  • Myocardial perfusion scan
  • Metastasis
  • Myocardial perfusion
  • Dosimetry
  • [18F]FDG PET/CT
  • Radioiodine
  • 99mTc-MIBI
  • Bone metastasis
  • Radiopharmaceutical
  • Radiolabeling
  • Differentiated thyroid carcinoma
  • Attenuation correction
  • Technetium-99m
  • Differentiated thyroid cancer
  • coronary artery disease
  • Sentinel lymph node
  • Positron emission tomography
  • Monte Carlo Simulation
  • 99mTc-MDP
  • Covid-19
  • Sentinel node
  • Iran
  • Radiopharmaceuticals
  • Hyperthyroidism
  • Absorbed dose
  • [99mTc]Tc-MDP
  • Renal scintigraphy
  • Radiation protection
  • Myocardial perfusion SPECT
  • Dipyridamole
  • Pulmonary embolism
  • False-positive
  • Radionuclide imaging
  • Tumor
  • I-131
  • Radioactive iodine
  • effective dose
  • 99mTc
  • Gamma camera
  • [99mTc]Tc-DMSA
  • Renography
  • HYNIC
  • Chitosan
  • PET-CT
  • Infection
  • Radionuclide therapy
  • Tc-99m MDP
  • Oncology
  • SPECT-CT
  • In-111
  • Copper-64
  • osteoporosis
  • Parathyroid adenoma
  • Breast
  • Therapy
  • Skeletal scintigraphy
  • Hyperparathyroidism
  • Delayed imaging
  • SUVmax
  • 177Lu
  • Ejection fraction
  • MRI
  • Osteomyelitis
  • fdg
  • Sub-diaphragmatic activity
  • Bleomycin
  • Google scholar
  • Cardiology
  • Iodine-131
  • Soft tissue uptake
  • Simulation
  • Kidney
  • Cancer
  • Optimization
  • Radioligand therapy
  • Imaging
  • [99mTc]Tc-EC
  • Sestamibi
  • Primary hyperparathyroidism
  • Bombesin
  • [99mTc]Tc-PSMA
  • Hydronephrosis
  • Multiple Myeloma
  • Phase analysis
  • Pitfall
  • Planar imaging
  • Image quality
  • Neuroendocrine tumor
  • Artificial intelligence
  • 18F-FDG PET/CT
  • Radiochemical purity
  • Sensitivity
  • Echocardiography
  • Holmium-166
  • Sm-153
  • Radiosynovectomy
  • Spatial resolution
  • Lymphoma
  • Fibrosarcoma
  • Colorectal cancer
  • Transient ischemic dilation
  • Evidence based medicine
  • Radiotherapy
  • [99mTc]Tc-MIBI
  • Artifacts
  • 99mTc-DMSA
  • Melanoma
  • Somatostatin
  • Gallium-67
  • DOTATOC
  • Thyroid gland
  • Myocardial uptake
  • DTPA
  • Occupational exposure
  • Artifact
  • myocardium
  • NCAT
  • cyclotron
  • Ischemic heart disease
  • Hepatocellular Carcinoma
  • Brain Perfusion SPECT
  • Malignancy
  • Molecular imaging
  • Ga-67
  • Salivary gland scintigraphy
  • Critical appraisal
  • Tc-99m antimony sulfide colloid
  • Meckel’s scan
  • Brain SPECT
  • Nuclear medicine staff
  • chemotherapy
  • Salivary Gland
  • Radionuclides
  • Radiolabeled peptide
  • Brain imaging
  • Eidolon
  • MIRD
  • Quality of Life
  • Composite
  • MIBI
  • Cardiac SPECT/CT
  • Re-injection
  • attenuation
  • BPAMD
  • Lead
  • Differential diagnosis
  • Parathyroid
  • Time-of-Flight
  • Gamma probe
  • Ultrasonography
  • Radiology
  • Pain palliation
  • Cardiac events
  • Thyroidectomy
  • Image reconstruction
  • Epiphora
  • Extraosseous uptake
  • TENIS syndrome
  • Tc-99m sestamibi
  • Hybrid imaging
  • Staging
  • Differential renal function
  • Machine learning
  • Bone pain
  • mCRPC
  • Stability
  • 99mTc-MIBI scintigraphy
  • Breast uptake
  • Radionuclide
  • Meningioma
  • Meckel’s diverticulum
  • menopause
  • Left ventricular volume
  • Indium-111
  • Lung perfusion scintigraphy
  • Gastrointestinal bleeding
  • Renal cell carcinoma
  • Blue dye
  • SCImago journal rank indicator
  • Platelets
  • Pain
  • Dacryocystorhinostomy